Praxis Precision Medicines, Inc.
PRAX
$346.84
$3.641.06%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 77.99M | 77.51M | 65.80M | 63.01M | 60.81M |
| Gross Profit | -77.99M | -77.51M | -65.80M | -63.01M | -60.81M |
| SG&A Expenses | 27.87M | 19.54M | 12.56M | 13.06M | 13.92M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 105.86M | 97.04M | 78.36M | 76.07M | 74.73M |
| Operating Income | -105.86M | -97.04M | -78.36M | -76.07M | -74.73M |
| Income Before Tax | -92.56M | -88.91M | -73.93M | -71.13M | -69.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -92.56M | -88.91M | -73.93M | -71.13M | -69.30M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -92.56M | -88.91M | -73.93M | -71.13M | -69.30M |
| EBIT | -105.86M | -97.04M | -78.36M | -76.07M | -74.73M |
| EBITDA | -105.82M | -97.02M | -78.34M | -76.02M | -74.68M |
| EPS Basic | -3.20 | -3.50 | -3.36 | -3.31 | -3.29 |
| Normalized Basic EPS | -2.02 | -2.28 | -2.10 | -2.07 | -2.09 |
| EPS Diluted | -3.20 | -3.50 | -3.36 | -3.31 | -3.29 |
| Normalized Diluted EPS | -2.02 | -2.28 | -2.10 | -2.07 | -2.09 |
| Average Basic Shares Outstanding | 28.88M | 25.41M | 21.98M | 21.47M | 21.06M |
| Average Diluted Shares Outstanding | 28.88M | 25.41M | 21.98M | 21.47M | 21.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |